Trust is a major factor in determining where B2B buyers choose to do business, and inflation has only made them more wary. Get out in front with a clear pricing narrative.
The answer is probably somewhere in between—and CEOs need to evaluate options now, particularly if depressed valuation has made the company a target.
Silicon Valley’s bad boy is launching one of the richest IPOs in history; but will it gain the admiration of regulators, politicians, and most importantly, its drivers?
Many U.S. manufacturers struggle to balance sustainability and the desire to make products at home with the need to reduce costs and boost their margins. Here’s one that’s succeeding.
While drug company CEOs are increasingly pilloried by activists following a series of price-hike scandals, at least two business leaders are advocating a pricing model they say could help restore the industry’s credibility.